Filing metadata

Accession number
0001714899-22-000101
Form type
Form 4/A
Filer
Denali Therapeutics Inc.
CIK
CIK 1714899
Filed
Jun 28, 2022
Reporting period
Mar 23, 2022
Description
Insider transaction

Explore SEC Filings Hub